While Cellebrite DI Ltd has underperformed by -0.09%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CLBT rose by 97.97%, with highs and lows ranging from $12.50 to $5.22, whereas the simple moving average jumped by 42.71% in the last 200 days.
On March 13, 2024, William Blair Upgraded Cellebrite DI Ltd (NASDAQ: CLBT) to Outperform. A report published by BofA Securities on February 16, 2024, Upgraded its rating to ‘Buy’ for CLBT. Craig Hallum also rated CLBT shares as ‘Buy’, setting a target price of $11 on the company’s shares in an initiating report dated July 19, 2023. BofA Securities August 12, 2022d its ‘Buy’ rating to ‘Neutral’ for CLBT, as published in its report on August 12, 2022. JP Morgan’s report from February 24, 2022 suggests a price prediction of $10.50 for CLBT shares, giving the stock a ‘Overweight’ rating. Deutsche Bank also rated the stock as ‘Buy’.
Analysis of Cellebrite DI Ltd (CLBT)
Further, the quarter-over-quarter increase in sales is 25.66%, showing a positive trend in the upcoming months.
One of the most important indicators of Cellebrite DI Ltd’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -150.08% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.62, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and CLBT is recording 977.44K average volume. On a monthly basis, the volatility of the stock is set at 3.07%, whereas on a weekly basis, it is put at 2.71%, with a loss of -1.60% over the past seven days. Furthermore, long-term investors anticipate a median target price of $13.17, showing growth from the present price of $11.68, which can serve as yet another indication of whether CLBT is worth investing in or should be passed over.
How Do You Analyze Cellebrite DI Ltd Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 72.93%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 26.51% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CLBT shares are owned by institutional investors to the tune of 26.51% at present.
